BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24377556)

  • 1. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.
    Kempf E; Desamericq G; Vieites B; Diaz-Padilla I; Calvo E; Estevez P; Garcia-Arreza A; Martinez-Maestre MA; Duran I
    Clin Transl Oncol; 2017 Feb; 19(2):173-179. PubMed ID: 27193130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience.
    Elashry R; Hemida R; Goda H; Abdel-Hady el-S
    J Exp Ther Oncol; 2013; 10(3):181-7. PubMed ID: 24416992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
    Qin B; Xu W; Li Y
    Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
    Cheng H; Peng J; Yang Z; Zhang G
    Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
    Hanvic B; Lecuru F; Vanacker H; Pautier P; Narducci F; Cherifi F; Floquet A; Angeles MA; Berton D; Pomel C; Kalbacher E; Provansal M; Fernandez Y; Rouge TM; Roméo C; Laas E; Morice P; Hudry D; Meriaux E; Guyon F; Illac-Vauquelin C; Selle F; Meeus P; Genestie C; Salleron J; Ray-Coquard I
    Gynecol Oncol; 2023 Jul; 174():190-199. PubMed ID: 37210929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
    Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 15. Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study.
    Qian Q; You Y; Yang J; Cao D; Zhu Z; Wu M; Chen J; Lang J; Shen K
    BMC Cancer; 2015 Apr; 15():270. PubMed ID: 25886261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
    Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
    Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.
    Leitao MM; Boyd J; Hummer A; Olvera N; Arroyo CD; Venkatraman E; Baergen RN; Dizon DS; Barakat RR; Soslow RA
    Am J Surg Pathol; 2004 Feb; 28(2):147-59. PubMed ID: 15043303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.